Skip to main content

Table 2 Treatment substances administered to horses of the three treatment groups on days 1, 22 and 78

From: Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma

Vaccine component

Dose per injection

 

Group eqIL12/18

Group hgp100

Group htyr

MIDGE-Th1

200 μg

200 μg

200 μg

eqIL12

MIDGE-Th1

200 μg

200 μg

200 μg

eqILRAPIL18

MIDGE-Th1

-

500 μg

-

hgp100

MIDGE-Th1

-

-

500 μg

htyr

SAINT 18

0.35 μmol

0.675 μmol

0.675 μmol